Cefdinir recalls

The FDA has published 11 recalls involving Cefdinir since 2013. The latest was reported on 5 Jun 2024. Most were for packaging defects. Lupin Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls11since 2013

Last 12 months0reported

Class I00% of total

Ongoing0latest 5 Jun 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 9 82%Class III 2 18%

Why cefdinir is recalled

Companies

Lupin Pharmaceuticals1091%
Teva Pharmaceuticals USA19%

By year

2024327%
202019%
2019545%
201819%
201319%

All cefdinir recalls, newest first

11 total

Reported	Class	Recall	Company	Reason	Where
5 Jun 2024Drug	CLASS II	Cefdinir for Oral Suspension USP, 250 mg recalledCefdinir	Lupin Pharmaceuticals	Packaging Defects	Nationwide
22 May 2024Drug	CLASS II	Cefdinir for Oral Suspension USP 125 mg/ when reconstituted) recalledCefdinir	Lupin Pharmaceuticals	Foreign Material	Nationwide
22 May 2024Drug	CLASS II	Cefdinir for Oral Suspension USP 250 mg/ when reconstituted) recalledCefdinir	Lupin Pharmaceuticals	Foreign Material	Nationwide
29 Jul 2020Drug	CLASS II	Cefdinir for Oral Suspension USP, 250 mg recalledCefdinir	Lupin Pharmaceuticals	Potency & Assay	Nationwide
13 Nov 2019Drug	CLASS III	Cefdinir for Oral Suspension USP, 125 mg recalledCefdinir	Lupin Pharmaceuticals	Packaging Defects	Nationwide
13 Nov 2019Drug	CLASS III	Cefdinir for Oral Suspension USP, 250 mg recalledCefdinir	Lupin Pharmaceuticals	Other	Nationwide
5 Jun 2019Drug	CLASS II	Cefdinir for Oral Suspension USP, 250mg/, Powder for oral suspension recalledCefdinir	Lupin Pharmaceuticals	Foreign Material	Nationwide
16 Jan 2019Drug	CLASS II	Cefdinir for Oral Suspension USP, 250mg recalledCefdinir	Lupin Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
16 Jan 2019Drug	CLASS II	Cefdinir for Oral Suspension USP, 125mg recalledCefdinir	Lupin Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
25 Apr 2018Drug	CLASS II	Lupin Cefdinir powder for Oral Suspension USP, 250 mg recalledCefdinir	Lupin Pharmaceuticals	Potency & Assay	Nationwide

Should you stop taking Cefdinir?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.